Disclosures for "Global vs. Focal White Matter Injury Demonstrates Varying Cerebral Visual Impairment "
-
Miss Da Cruz has nothing to disclose.
-
Dr. Tambala has nothing to disclose.
-
Ms. Lynch has nothing to disclose.
-
Ms. Manley has nothing to disclose.
-
Ms. Bambery has nothing to disclose.
-
Mr. Kelly has nothing to disclose.
-
Dr. Alhadid has nothing to disclose.
-
Dr. Merabet has nothing to disclose.
-
Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altas Venture Capital. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Musolino has received research support from National Institute of Health-NINDS-R01. The institution of Dr. Musolino has received research support from Angea Biotherapeutics. The institution of Dr. Musolino has received research support from Minoryx Pharmaceuticals. Dr. Musolino has received publishing royalties from a publication relating to health care.